Life Science & Biotech

Tenants trickling in to Purdue’s technology centerRestricted Content

August 17, 2009
Chris O'Malley
For a city feverishly growing its technology and life sciences sectors, it seemed a bit anticlimactic last January when Purdue University dedicated its new technology center with only one tenant. But the lone tenant in the $12.8 million complex, FlamencoNets, a high-tech telecommunications firm, is about to get some company.
More

Abatement approval paves way for Covance jobs

August 12, 2009
Scott Olson
The Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add 315 jobs at its Greenfield Laboratories.
More

Cook predicts blockbuster with new stent

August 12, 2009
J.K. Wall
Bloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will be a blockbuster.
More

Emerging life sciences companies grabbing more in government grantsRestricted Content

August 10, 2009
Chris O'Malley
More emerging life science companies have found life in the form of federal Small Business Innovation Research grants.
More

POWER BREAKFAST: Panel applauds progress, identifies challenges

August 10, 2009
 IBJ Staff
A panel of five leaders of the state’s life sciences industry took on a wide range of topics July 24 at IBJ’s Power Breakfast at the Westin Indianapolis.
More

Lilly's Effient launch just one of its many challengesRestricted Content

August 3, 2009
Greg Andrews
Eli Lilly and Co. has blasted past analysts’ earnings projections for two straight quarters. But if Lilly officials take that as a sign they can breathe easier, they need only flip through a stack of Wall Street research reports on the company.
More

Lilly software spinoff Maaguzi sells for $11 millionRestricted Content

August 3, 2009
Chris O'Malley
Investors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though it’s far from the lucrative payoff they’d once imagined.
More

Dow Chemical seems poised to keep AgroSciencesRestricted Content

August 3, 2009
Peter Schnitzler
Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But chances that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit appear to have decreased.
More

Is Indiana coming out of venture capital swoon?

August 3, 2009
 IBJ Staff
Carmel-based Dormir LLC’s announcement July 29 of $12 million in venture financing was the second local life sciences deal announced in July. It could suggest a turnaround from a woeful second-quarter performance, when Indiana life sciences firms announced zero venture capital deals.
More

Dow Agro sale still possible, but less likely

July 30, 2009
Peter Schnitzler
Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But chances that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit have decreased.
More

Dow AgroSciences names new CEO

July 29, 2009
Chris O'Malley, J.K. Wall
Indianapolis-based Dow AgroSciences LLC will have a new CEO after its parent organization moves Jerome Peribere into a new position, the company announced today. Antonio Galindez, 54, vice president of Dow AgroSciences' crops business, will step into the top job.
More

Dow AgroSciences names new CEO

July 29, 2009
J.K. Wall
Indianapolis-based Dow AgroSciences LLC will have a new CEO after its parent organization moves Jerome Peribere into a new position, the company announced today.
More

Dow Agrosciences introduces genetically modified corn seedRestricted Content

July 27, 2009
 IBJ Staff
Even after a string of acquisitions, Dow AgroSciences is a bit player in the seed business. But the new genetically modified corn it developed with St. Louis-based giant Monsanto Co. finally provides the breakthrough product that could grow its seed sales substantially.
More

Potential obesity breakthrough boosts Marcadia

July 20, 2009
J.K. Wall
Favorable article in prestigious journal could draw attention to Carmel biotech startup.
More

Professors go online to revolutionize drug discoveryRestricted Content

July 20, 2009
 IBJ Staff
Two chemistry professors at IUPUI are laboring to create the McDonald’s of research laboratories—low-cost and all over the world.
More

Lilly cancer drug OK'd for new use

July 6, 2009
J.K. Wall
Eli Lilly and Co.'s top rising-star drug has been approved by U.S. regulators for a new use, an event that could boost sales of the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer for certain patients, Lilly announced today.
More

Minority suppliers diversifying into life sciencesRestricted Content

July 6, 2009
Scott Olson
The Indiana Minority Supplier Development Council has made life sciences companies its latest target—part of an even larger effort to attract minorities to the burgeoning life sciences industry under way on a national scale.
More

Board battle brewing at BioanalyticalRestricted Content

June 29, 2009
 IBJ Staff
West Lafayette-based life sciences contract research firm Bioanalytical Systems Inc. has five directors on its board. If company founder Pete Kissinger has his way, four of them will soon be replaced.
More

Profs trying to revolutionize drug discovery processRestricted Content

June 22, 2009
 IBJ Staff
Two chemistry professors at IUPUI are laboring to create the McDonald's of research laboratories—a model that's low-cost and can spread around the world.
More

Bioanalytical Systems founder fights to be heardRestricted Content

May 4, 2009
Peter Schnitzler
It took Pete and Candace Kissinger 33 years to build West Lafayette-based Bioanalytical Systems Inc. into one of the largest contract research firms in Indiana's life science sector. It took just a year and a half for them to turn against the company's new management.
More

With pharma famine looming, Lilly relying on snack-size dealsRestricted Content

May 4, 2009
J.K. Wall
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year, Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.
More

Stem cell discovery promises health care revolutionRestricted Content

April 13, 2009
Bloomberg News
Scientists are using a new stem-cell technique that may someday revolutionize care for disorders as diverse as diabetes, Alzheimer's disease and muscular dystrophy.
More

Indiana playing trailblazing role in drive to tailor pharmaceuticals to genetic makeup of individualsRestricted Content

April 13, 2009
Chris O'Malley
Indiana is becoming not only a hotbed of "pharmacogenomics" research, but also a trailblazer in finding practical ways to use it on the practitioner level.
More

Linking specialties is key to life sciencesRestricted Content

March 30, 2009
The Indiana Innovation Alliance will bring together researchers from both IU and Purdue and keep much intellectual property innovation in Indiana.
More

Executives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cellsRestricted Content

March 23, 2009
J.K. Wall
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells.
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT